Is Atypical Bisphosphonate Treatment Response a Risk Factor for Atypical Femoral Fracture?: Commentary on an article by Kyung-Jae Lee, MD, et al.: "T-Score Discordance of Bone Mineral Density in Patients with Atypical Femoral Fracture". [electronic resource]
- The Journal of bone and joint surgery. American volume 10 2017
- e105 p. digital
Publication Type: Journal Article; Comment
1535-1386
10.2106/JBJS.17.00721 doi
Bone Density Bone Density Conservation Agents Diphosphonates Femoral Fractures Humans Risk Factors